March 6, 2008

Duke University
Fuqua School of Business
Durham, NC

MedTech 2008 Conference

Agenda

Driving Directions to Duke University - Fuqua School of Business.

Click here for a printer-friendly agenda.

Thursday, March 6

Duke University - Fuqua School of Business, Durham, NC

8 a.m. – 9 a.m. Breakfast & Registration  
9 a.m. – 9:45 a.m. Opening Remarks and Featured Speaker

Jeff Hoffman

Managing Director & Head of West Coast Healthcare Investment Banking, J.P. Morgan Securities Inc.
9:45 a.m. – 10:30 a.m. Featured Speaker

Ronald W. Dollens

Former President and CEO, Guidant Corporation
10:30 a.m. – 10:45 a.m. Break  
10:45 a.m. – 12 noon Featured Panel Session

Alternatives to Growing a Medical Device Company

Advanced medical technology companies face many challenges during various growth stages—in particular financing needs and strategies. While the traditional venture capital path is one that many medical technologies companies have pursued successfully, there are multiple alternative financing paths that can also lead to successful companies. Hear from a panel of industry leading investors and entrepreneurs on traditional and alternative pathways that medical device companies can take to grow their company.

Moderator:

  • Barry Myers, M.D., Ph.D., Anderson-Rupp Professor, Senior Associate Dean for Industrial Partnerships and Research Commercialization and Director, Duke University Center for Entrepreneurship and Research Commercialization

Panelists:

  • Kevin Connors, General Partner, Spray Venture Partners
  • David Milne, Managing Partner, SV Life Sciences
  • Richard West, Chief Executive Officer, Advanced Liquid Logic, Inc.
  • Tim Willis, President & Chief Executive Officer, Kolis Scientific, Inc.
12 noon – 1:30 p.m. Lunch & Featured Speaker

Richard S. Stack, M.D.

President, Synecor, LLC
1:30 p.m. – 1:45 p.m. Break  
1:45 p.m. – 3 p.m. Featured Panel Session

Convergent Technologies Changing the Face of Medicine

“Convergence” means the integration of drugs, devices, nanotechnology, software, and electrical engineering into smart devices. Is it the great hope of the future for advanced medical technologies or just a lot of hype based upon 1 big product (drug eluting stents). Panelist will talk about practical realities, lessons learned from first generation combination products and their predictions for the future of convergence products.

Moderator:

Panelists:
3 p.m. – 3:10 p.m. Break  
3:10 p.m. – 4:15 p.m. Featured Panel Session

Global Clinical Trials

An important milestone for an early stage, advanced medical technology company is the selection of a site to test its new medical device for the first time. With regulatory hurdles increasing across Europe and Asia, companies are faced with a challenging environment for First-In-Man (FIM) testing. Once initial implants are completed attention turns to clinical trials, which are most often done outside of the U.S. This engaging and educational panel of industry experts will provide practical, experience-based stories of successful First-In-Man and global clinical trials.

Moderator:

Panelists:

  • James F. Buck, Vice President, Marketing & Business Development, InnerPulse, Inc.
  • H. Richard Davis, Chief Technology Officer, Tryton Medical, Inc.
  • John Funkhouser, President & Chief Executive Officer, nContact Surgical, Inc.
4:15 p.m. – 5 p.m. Closing Wine and Cheese Reception